Global Celecoxib Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period.
The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Celecoxib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Celecoxib market.
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
Key Features:
The report on Celecoxib market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Celecoxib market. It may include historical data, market segmentation by Type (e.g., 50mg, 100mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Celecoxib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Celecoxib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Celecoxib industry. This include advancements in Celecoxib technology, Celecoxib new entrants, Celecoxib new investment, and other innovations that are shaping the future of Celecoxib.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Celecoxib market. It includes factors influencing customer ' purchasing decisions, preferences for Celecoxib product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Celecoxib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Celecoxib market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Celecoxib market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Celecoxib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Celecoxib market.
Market Segmentation:
Celecoxib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Celecoxib market?
What factors are driving Celecoxib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celecoxib market opportunities vary by end market size?
How does Celecoxib break out type, application?
According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period.
The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Celecoxib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Celecoxib market.
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
Key Features:
The report on Celecoxib market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Celecoxib market. It may include historical data, market segmentation by Type (e.g., 50mg, 100mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Celecoxib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Celecoxib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Celecoxib industry. This include advancements in Celecoxib technology, Celecoxib new entrants, Celecoxib new investment, and other innovations that are shaping the future of Celecoxib.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Celecoxib market. It includes factors influencing customer ' purchasing decisions, preferences for Celecoxib product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Celecoxib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Celecoxib market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Celecoxib market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Celecoxib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Celecoxib market.
Market Segmentation:
Celecoxib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 50mg
- 100mg
- 200mg
- 400mg
- Rheumatoid arthritis
- osteoarthritis
- Acute pain
- Musculoskeletal pain
- Other diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc
- Teva
- Mylan
- Apotex
- Lupin
- Hengrui Medicine
What is the 10-year outlook for the global Celecoxib market?
What factors are driving Celecoxib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celecoxib market opportunities vary by end market size?
How does Celecoxib break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Celecoxib Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Celecoxib by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Celecoxib by Country/Region, 2019, 2023 & 2030
2.2 Celecoxib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.2.3 200mg
2.2.4 400mg
2.3 Celecoxib Sales by Type
2.3.1 Global Celecoxib Sales Market Share by Type (2019-2024)
2.3.2 Global Celecoxib Revenue and Market Share by Type (2019-2024)
2.3.3 Global Celecoxib Sale Price by Type (2019-2024)
2.4 Celecoxib Segment by Application
2.4.1 Rheumatoid arthritis
2.4.2 osteoarthritis
2.4.3 Acute pain
2.4.4 Musculoskeletal pain
2.4.5 Other diseases
2.5 Celecoxib Sales by Application
2.5.1 Global Celecoxib Sale Market Share by Application (2019-2024)
2.5.2 Global Celecoxib Revenue and Market Share by Application (2019-2024)
2.5.3 Global Celecoxib Sale Price by Application (2019-2024)
3 GLOBAL CELECOXIB BY COMPANY
3.1 Global Celecoxib Breakdown Data by Company
3.1.1 Global Celecoxib Annual Sales by Company (2019-2024)
3.1.2 Global Celecoxib Sales Market Share by Company (2019-2024)
3.2 Global Celecoxib Annual Revenue by Company (2019-2024)
3.2.1 Global Celecoxib Revenue by Company (2019-2024)
3.2.2 Global Celecoxib Revenue Market Share by Company (2019-2024)
3.3 Global Celecoxib Sale Price by Company
3.4 Key Manufacturers Celecoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celecoxib Product Location Distribution
3.4.2 Players Celecoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CELECOXIB BY GEOGRAPHIC REGION
4.1 World Historic Celecoxib Market Size by Geographic Region (2019-2024)
4.1.1 Global Celecoxib Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Celecoxib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Celecoxib Market Size by Country/Region (2019-2024)
4.2.1 Global Celecoxib Annual Sales by Country/Region (2019-2024)
4.2.2 Global Celecoxib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Celecoxib Sales Growth
4.4 APAC Celecoxib Sales Growth
4.5 Europe Celecoxib Sales Growth
4.6 Middle East & Africa Celecoxib Sales Growth
5 AMERICAS
5.1 Americas Celecoxib Sales by Country
5.1.1 Americas Celecoxib Sales by Country (2019-2024)
5.1.2 Americas Celecoxib Revenue by Country (2019-2024)
5.2 Americas Celecoxib Sales by Type
5.3 Americas Celecoxib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib Sales by Region
6.1.1 APAC Celecoxib Sales by Region (2019-2024)
6.1.2 APAC Celecoxib Revenue by Region (2019-2024)
6.2 APAC Celecoxib Sales by Type
6.3 APAC Celecoxib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Celecoxib by Country
7.1.1 Europe Celecoxib Sales by Country (2019-2024)
7.1.2 Europe Celecoxib Revenue by Country (2019-2024)
7.2 Europe Celecoxib Sales by Type
7.3 Europe Celecoxib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Celecoxib by Country
8.1.1 Middle East & Africa Celecoxib Sales by Country (2019-2024)
8.1.2 Middle East & Africa Celecoxib Revenue by Country (2019-2024)
8.2 Middle East & Africa Celecoxib Sales by Type
8.3 Middle East & Africa Celecoxib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celecoxib
10.3 Manufacturing Process Analysis of Celecoxib
10.4 Industry Chain Structure of Celecoxib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celecoxib Distributors
11.3 Celecoxib Customer
12 WORLD FORECAST REVIEW FOR CELECOXIB BY GEOGRAPHIC REGION
12.1 Global Celecoxib Market Size Forecast by Region
12.1.1 Global Celecoxib Forecast by Region (2025-2030)
12.1.2 Global Celecoxib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Celecoxib Forecast by Type
12.7 Global Celecoxib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Celecoxib Product Portfolios and Specifications
13.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Celecoxib Product Portfolios and Specifications
13.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Celecoxib Product Portfolios and Specifications
13.3.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Apotex
13.4.1 Apotex Company Information
13.4.2 Apotex Celecoxib Product Portfolios and Specifications
13.4.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Apotex Main Business Overview
13.4.5 Apotex Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin Celecoxib Product Portfolios and Specifications
13.5.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Hengrui Medicine
13.6.1 Hengrui Medicine Company Information
13.6.2 Hengrui Medicine Celecoxib Product Portfolios and Specifications
13.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hengrui Medicine Main Business Overview
13.6.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Celecoxib Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Celecoxib by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Celecoxib by Country/Region, 2019, 2023 & 2030
2.2 Celecoxib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.2.3 200mg
2.2.4 400mg
2.3 Celecoxib Sales by Type
2.3.1 Global Celecoxib Sales Market Share by Type (2019-2024)
2.3.2 Global Celecoxib Revenue and Market Share by Type (2019-2024)
2.3.3 Global Celecoxib Sale Price by Type (2019-2024)
2.4 Celecoxib Segment by Application
2.4.1 Rheumatoid arthritis
2.4.2 osteoarthritis
2.4.3 Acute pain
2.4.4 Musculoskeletal pain
2.4.5 Other diseases
2.5 Celecoxib Sales by Application
2.5.1 Global Celecoxib Sale Market Share by Application (2019-2024)
2.5.2 Global Celecoxib Revenue and Market Share by Application (2019-2024)
2.5.3 Global Celecoxib Sale Price by Application (2019-2024)
3 GLOBAL CELECOXIB BY COMPANY
3.1 Global Celecoxib Breakdown Data by Company
3.1.1 Global Celecoxib Annual Sales by Company (2019-2024)
3.1.2 Global Celecoxib Sales Market Share by Company (2019-2024)
3.2 Global Celecoxib Annual Revenue by Company (2019-2024)
3.2.1 Global Celecoxib Revenue by Company (2019-2024)
3.2.2 Global Celecoxib Revenue Market Share by Company (2019-2024)
3.3 Global Celecoxib Sale Price by Company
3.4 Key Manufacturers Celecoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celecoxib Product Location Distribution
3.4.2 Players Celecoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CELECOXIB BY GEOGRAPHIC REGION
4.1 World Historic Celecoxib Market Size by Geographic Region (2019-2024)
4.1.1 Global Celecoxib Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Celecoxib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Celecoxib Market Size by Country/Region (2019-2024)
4.2.1 Global Celecoxib Annual Sales by Country/Region (2019-2024)
4.2.2 Global Celecoxib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Celecoxib Sales Growth
4.4 APAC Celecoxib Sales Growth
4.5 Europe Celecoxib Sales Growth
4.6 Middle East & Africa Celecoxib Sales Growth
5 AMERICAS
5.1 Americas Celecoxib Sales by Country
5.1.1 Americas Celecoxib Sales by Country (2019-2024)
5.1.2 Americas Celecoxib Revenue by Country (2019-2024)
5.2 Americas Celecoxib Sales by Type
5.3 Americas Celecoxib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib Sales by Region
6.1.1 APAC Celecoxib Sales by Region (2019-2024)
6.1.2 APAC Celecoxib Revenue by Region (2019-2024)
6.2 APAC Celecoxib Sales by Type
6.3 APAC Celecoxib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Celecoxib by Country
7.1.1 Europe Celecoxib Sales by Country (2019-2024)
7.1.2 Europe Celecoxib Revenue by Country (2019-2024)
7.2 Europe Celecoxib Sales by Type
7.3 Europe Celecoxib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Celecoxib by Country
8.1.1 Middle East & Africa Celecoxib Sales by Country (2019-2024)
8.1.2 Middle East & Africa Celecoxib Revenue by Country (2019-2024)
8.2 Middle East & Africa Celecoxib Sales by Type
8.3 Middle East & Africa Celecoxib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celecoxib
10.3 Manufacturing Process Analysis of Celecoxib
10.4 Industry Chain Structure of Celecoxib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celecoxib Distributors
11.3 Celecoxib Customer
12 WORLD FORECAST REVIEW FOR CELECOXIB BY GEOGRAPHIC REGION
12.1 Global Celecoxib Market Size Forecast by Region
12.1.1 Global Celecoxib Forecast by Region (2025-2030)
12.1.2 Global Celecoxib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Celecoxib Forecast by Type
12.7 Global Celecoxib Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Celecoxib Product Portfolios and Specifications
13.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Celecoxib Product Portfolios and Specifications
13.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Celecoxib Product Portfolios and Specifications
13.3.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Apotex
13.4.1 Apotex Company Information
13.4.2 Apotex Celecoxib Product Portfolios and Specifications
13.4.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Apotex Main Business Overview
13.4.5 Apotex Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin Celecoxib Product Portfolios and Specifications
13.5.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Hengrui Medicine
13.6.1 Hengrui Medicine Company Information
13.6.2 Hengrui Medicine Celecoxib Product Portfolios and Specifications
13.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hengrui Medicine Main Business Overview
13.6.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Celecoxib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Celecoxib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Major Players of 200mg
Table 6. Major Players of 400mg
Table 7. Global Celecoxib Sales by Type (2019-2024) & (K Units)
Table 8. Global Celecoxib Sales Market Share by Type (2019-2024)
Table 9. Global Celecoxib Revenue by Type (2019-2024) & ($ million)
Table 10. Global Celecoxib Revenue Market Share by Type (2019-2024)
Table 11. Global Celecoxib Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Celecoxib Sales by Application (2019-2024) & (K Units)
Table 13. Global Celecoxib Sales Market Share by Application (2019-2024)
Table 14. Global Celecoxib Revenue by Application (2019-2024)
Table 15. Global Celecoxib Revenue Market Share by Application (2019-2024)
Table 16. Global Celecoxib Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Celecoxib Sales by Company (2019-2024) & (K Units)
Table 18. Global Celecoxib Sales Market Share by Company (2019-2024)
Table 19. Global Celecoxib Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Celecoxib Revenue Market Share by Company (2019-2024)
Table 21. Global Celecoxib Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Celecoxib Producing Area Distribution and Sales Area
Table 23. Players Celecoxib Products Offered
Table 24. Celecoxib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Celecoxib Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Celecoxib Sales Market Share Geographic Region (2019-2024)
Table 29. Global Celecoxib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Celecoxib Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Celecoxib Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Celecoxib Sales Market Share by Country/Region (2019-2024)
Table 33. Global Celecoxib Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Celecoxib Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Celecoxib Sales by Country (2019-2024) & (K Units)
Table 36. Americas Celecoxib Sales Market Share by Country (2019-2024)
Table 37. Americas Celecoxib Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Celecoxib Revenue Market Share by Country (2019-2024)
Table 39. Americas Celecoxib Sales by Type (2019-2024) & (K Units)
Table 40. Americas Celecoxib Sales by Application (2019-2024) & (K Units)
Table 41. APAC Celecoxib Sales by Region (2019-2024) & (K Units)
Table 42. APAC Celecoxib Sales Market Share by Region (2019-2024)
Table 43. APAC Celecoxib Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Celecoxib Revenue Market Share by Region (2019-2024)
Table 45. APAC Celecoxib Sales by Type (2019-2024) & (K Units)
Table 46. APAC Celecoxib Sales by Application (2019-2024) & (K Units)
Table 47. Europe Celecoxib Sales by Country (2019-2024) & (K Units)
Table 48. Europe Celecoxib Sales Market Share by Country (2019-2024)
Table 49. Europe Celecoxib Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Celecoxib Revenue Market Share by Country (2019-2024)
Table 51. Europe Celecoxib Sales by Type (2019-2024) & (K Units)
Table 52. Europe Celecoxib Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Celecoxib Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Celecoxib Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Celecoxib Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Celecoxib Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Celecoxib Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Celecoxib Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Celecoxib
Table 60. Key Market Challenges & Risks of Celecoxib
Table 61. Key Industry Trends of Celecoxib
Table 62. Celecoxib Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Celecoxib Distributors List
Table 65. Celecoxib Customer List
Table 66. Global Celecoxib Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Celecoxib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Celecoxib Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Celecoxib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Celecoxib Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Celecoxib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Celecoxib Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Celecoxib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Celecoxib Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Celecoxib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Celecoxib Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Celecoxib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Celecoxib Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Celecoxib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Pfizer Inc Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Inc Celecoxib Product Portfolios and Specifications
Table 82. Pfizer Inc Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Pfizer Inc Main Business
Table 84. Pfizer Inc Latest Developments
Table 85. Teva Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva Celecoxib Product Portfolios and Specifications
Table 87. Teva Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Teva Main Business
Table 89. Teva Latest Developments
Table 90. Mylan Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 91. Mylan Celecoxib Product Portfolios and Specifications
Table 92. Mylan Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Mylan Main Business
Table 94. Mylan Latest Developments
Table 95. Apotex Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 96. Apotex Celecoxib Product Portfolios and Specifications
Table 97. Apotex Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Apotex Main Business
Table 99. Apotex Latest Developments
Table 100. Lupin Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 101. Lupin Celecoxib Product Portfolios and Specifications
Table 102. Lupin Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Lupin Main Business
Table 104. Lupin Latest Developments
Table 105. Hengrui Medicine Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 106. Hengrui Medicine Celecoxib Product Portfolios and Specifications
Table 107. Hengrui Medicine Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hengrui Medicine Main Business
Table 109. Hengrui Medicine Latest Developments
Table 1. Celecoxib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Celecoxib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Major Players of 200mg
Table 6. Major Players of 400mg
Table 7. Global Celecoxib Sales by Type (2019-2024) & (K Units)
Table 8. Global Celecoxib Sales Market Share by Type (2019-2024)
Table 9. Global Celecoxib Revenue by Type (2019-2024) & ($ million)
Table 10. Global Celecoxib Revenue Market Share by Type (2019-2024)
Table 11. Global Celecoxib Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Celecoxib Sales by Application (2019-2024) & (K Units)
Table 13. Global Celecoxib Sales Market Share by Application (2019-2024)
Table 14. Global Celecoxib Revenue by Application (2019-2024)
Table 15. Global Celecoxib Revenue Market Share by Application (2019-2024)
Table 16. Global Celecoxib Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Celecoxib Sales by Company (2019-2024) & (K Units)
Table 18. Global Celecoxib Sales Market Share by Company (2019-2024)
Table 19. Global Celecoxib Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Celecoxib Revenue Market Share by Company (2019-2024)
Table 21. Global Celecoxib Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Celecoxib Producing Area Distribution and Sales Area
Table 23. Players Celecoxib Products Offered
Table 24. Celecoxib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Celecoxib Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Celecoxib Sales Market Share Geographic Region (2019-2024)
Table 29. Global Celecoxib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Celecoxib Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Celecoxib Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Celecoxib Sales Market Share by Country/Region (2019-2024)
Table 33. Global Celecoxib Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Celecoxib Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Celecoxib Sales by Country (2019-2024) & (K Units)
Table 36. Americas Celecoxib Sales Market Share by Country (2019-2024)
Table 37. Americas Celecoxib Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Celecoxib Revenue Market Share by Country (2019-2024)
Table 39. Americas Celecoxib Sales by Type (2019-2024) & (K Units)
Table 40. Americas Celecoxib Sales by Application (2019-2024) & (K Units)
Table 41. APAC Celecoxib Sales by Region (2019-2024) & (K Units)
Table 42. APAC Celecoxib Sales Market Share by Region (2019-2024)
Table 43. APAC Celecoxib Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Celecoxib Revenue Market Share by Region (2019-2024)
Table 45. APAC Celecoxib Sales by Type (2019-2024) & (K Units)
Table 46. APAC Celecoxib Sales by Application (2019-2024) & (K Units)
Table 47. Europe Celecoxib Sales by Country (2019-2024) & (K Units)
Table 48. Europe Celecoxib Sales Market Share by Country (2019-2024)
Table 49. Europe Celecoxib Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Celecoxib Revenue Market Share by Country (2019-2024)
Table 51. Europe Celecoxib Sales by Type (2019-2024) & (K Units)
Table 52. Europe Celecoxib Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Celecoxib Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Celecoxib Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Celecoxib Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Celecoxib Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Celecoxib Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Celecoxib Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Celecoxib
Table 60. Key Market Challenges & Risks of Celecoxib
Table 61. Key Industry Trends of Celecoxib
Table 62. Celecoxib Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Celecoxib Distributors List
Table 65. Celecoxib Customer List
Table 66. Global Celecoxib Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Celecoxib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Celecoxib Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Celecoxib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Celecoxib Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Celecoxib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Celecoxib Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Celecoxib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Celecoxib Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Celecoxib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Celecoxib Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Celecoxib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Celecoxib Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Celecoxib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Pfizer Inc Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Inc Celecoxib Product Portfolios and Specifications
Table 82. Pfizer Inc Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Pfizer Inc Main Business
Table 84. Pfizer Inc Latest Developments
Table 85. Teva Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 86. Teva Celecoxib Product Portfolios and Specifications
Table 87. Teva Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Teva Main Business
Table 89. Teva Latest Developments
Table 90. Mylan Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 91. Mylan Celecoxib Product Portfolios and Specifications
Table 92. Mylan Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Mylan Main Business
Table 94. Mylan Latest Developments
Table 95. Apotex Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 96. Apotex Celecoxib Product Portfolios and Specifications
Table 97. Apotex Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Apotex Main Business
Table 99. Apotex Latest Developments
Table 100. Lupin Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 101. Lupin Celecoxib Product Portfolios and Specifications
Table 102. Lupin Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Lupin Main Business
Table 104. Lupin Latest Developments
Table 105. Hengrui Medicine Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 106. Hengrui Medicine Celecoxib Product Portfolios and Specifications
Table 107. Hengrui Medicine Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Hengrui Medicine Main Business
Table 109. Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Picture of Celecoxib
Figure 2. Celecoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celecoxib Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Celecoxib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Celecoxib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 100mg
Figure 11. Product Picture of 200mg
Figure 12. Product Picture of 400mg
Figure 13. Global Celecoxib Sales Market Share by Type in 2023
Figure 14. Global Celecoxib Revenue Market Share by Type (2019-2024)
Figure 15. Celecoxib Consumed in Rheumatoid arthritis
Figure 16. Global Celecoxib Market: Rheumatoid arthritis (2019-2024) & (K Units)
Figure 17. Celecoxib Consumed in osteoarthritis
Figure 18. Global Celecoxib Market: osteoarthritis (2019-2024) & (K Units)
Figure 19. Celecoxib Consumed in Acute pain
Figure 20. Global Celecoxib Market: Acute pain (2019-2024) & (K Units)
Figure 21. Celecoxib Consumed in Musculoskeletal pain
Figure 22. Global Celecoxib Market: Musculoskeletal pain (2019-2024) & (K Units)
Figure 23. Celecoxib Consumed in Other diseases
Figure 24. Global Celecoxib Market: Other diseases (2019-2024) & (K Units)
Figure 25. Global Celecoxib Sales Market Share by Application (2023)
Figure 26. Global Celecoxib Revenue Market Share by Application in 2023
Figure 27. Celecoxib Sales Market by Company in 2023 (K Units)
Figure 28. Global Celecoxib Sales Market Share by Company in 2023
Figure 29. Celecoxib Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Celecoxib Revenue Market Share by Company in 2023
Figure 31. Global Celecoxib Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Celecoxib Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Celecoxib Sales 2019-2024 (K Units)
Figure 34. Americas Celecoxib Revenue 2019-2024 ($ Millions)
Figure 35. APAC Celecoxib Sales 2019-2024 (K Units)
Figure 36. APAC Celecoxib Revenue 2019-2024 ($ Millions)
Figure 37. Europe Celecoxib Sales 2019-2024 (K Units)
Figure 38. Europe Celecoxib Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Celecoxib Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Celecoxib Revenue 2019-2024 ($ Millions)
Figure 41. Americas Celecoxib Sales Market Share by Country in 2023
Figure 42. Americas Celecoxib Revenue Market Share by Country in 2023
Figure 43. Americas Celecoxib Sales Market Share by Type (2019-2024)
Figure 44. Americas Celecoxib Sales Market Share by Application (2019-2024)
Figure 45. United States Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Celecoxib Sales Market Share by Region in 2023
Figure 50. APAC Celecoxib Revenue Market Share by Regions in 2023
Figure 51. APAC Celecoxib Sales Market Share by Type (2019-2024)
Figure 52. APAC Celecoxib Sales Market Share by Application (2019-2024)
Figure 53. China Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Celecoxib Sales Market Share by Country in 2023
Figure 61. Europe Celecoxib Revenue Market Share by Country in 2023
Figure 62. Europe Celecoxib Sales Market Share by Type (2019-2024)
Figure 63. Europe Celecoxib Sales Market Share by Application (2019-2024)
Figure 64. Germany Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Celecoxib Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Celecoxib Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Celecoxib Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Celecoxib Sales Market Share by Application (2019-2024)
Figure 73. Egypt Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Celecoxib in 2023
Figure 79. Manufacturing Process Analysis of Celecoxib
Figure 80. Industry Chain Structure of Celecoxib
Figure 81. Channels of Distribution
Figure 82. Global Celecoxib Sales Market Forecast by Region (2025-2030)
Figure 83. Global Celecoxib Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Celecoxib Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Celecoxib Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Celecoxib Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Celecoxib Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Celecoxib
Figure 2. Celecoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celecoxib Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Celecoxib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Celecoxib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 100mg
Figure 11. Product Picture of 200mg
Figure 12. Product Picture of 400mg
Figure 13. Global Celecoxib Sales Market Share by Type in 2023
Figure 14. Global Celecoxib Revenue Market Share by Type (2019-2024)
Figure 15. Celecoxib Consumed in Rheumatoid arthritis
Figure 16. Global Celecoxib Market: Rheumatoid arthritis (2019-2024) & (K Units)
Figure 17. Celecoxib Consumed in osteoarthritis
Figure 18. Global Celecoxib Market: osteoarthritis (2019-2024) & (K Units)
Figure 19. Celecoxib Consumed in Acute pain
Figure 20. Global Celecoxib Market: Acute pain (2019-2024) & (K Units)
Figure 21. Celecoxib Consumed in Musculoskeletal pain
Figure 22. Global Celecoxib Market: Musculoskeletal pain (2019-2024) & (K Units)
Figure 23. Celecoxib Consumed in Other diseases
Figure 24. Global Celecoxib Market: Other diseases (2019-2024) & (K Units)
Figure 25. Global Celecoxib Sales Market Share by Application (2023)
Figure 26. Global Celecoxib Revenue Market Share by Application in 2023
Figure 27. Celecoxib Sales Market by Company in 2023 (K Units)
Figure 28. Global Celecoxib Sales Market Share by Company in 2023
Figure 29. Celecoxib Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Celecoxib Revenue Market Share by Company in 2023
Figure 31. Global Celecoxib Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Celecoxib Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Celecoxib Sales 2019-2024 (K Units)
Figure 34. Americas Celecoxib Revenue 2019-2024 ($ Millions)
Figure 35. APAC Celecoxib Sales 2019-2024 (K Units)
Figure 36. APAC Celecoxib Revenue 2019-2024 ($ Millions)
Figure 37. Europe Celecoxib Sales 2019-2024 (K Units)
Figure 38. Europe Celecoxib Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Celecoxib Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Celecoxib Revenue 2019-2024 ($ Millions)
Figure 41. Americas Celecoxib Sales Market Share by Country in 2023
Figure 42. Americas Celecoxib Revenue Market Share by Country in 2023
Figure 43. Americas Celecoxib Sales Market Share by Type (2019-2024)
Figure 44. Americas Celecoxib Sales Market Share by Application (2019-2024)
Figure 45. United States Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Celecoxib Sales Market Share by Region in 2023
Figure 50. APAC Celecoxib Revenue Market Share by Regions in 2023
Figure 51. APAC Celecoxib Sales Market Share by Type (2019-2024)
Figure 52. APAC Celecoxib Sales Market Share by Application (2019-2024)
Figure 53. China Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Celecoxib Sales Market Share by Country in 2023
Figure 61. Europe Celecoxib Revenue Market Share by Country in 2023
Figure 62. Europe Celecoxib Sales Market Share by Type (2019-2024)
Figure 63. Europe Celecoxib Sales Market Share by Application (2019-2024)
Figure 64. Germany Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Celecoxib Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Celecoxib Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Celecoxib Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Celecoxib Sales Market Share by Application (2019-2024)
Figure 73. Egypt Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Celecoxib Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Celecoxib in 2023
Figure 79. Manufacturing Process Analysis of Celecoxib
Figure 80. Industry Chain Structure of Celecoxib
Figure 81. Channels of Distribution
Figure 82. Global Celecoxib Sales Market Forecast by Region (2025-2030)
Figure 83. Global Celecoxib Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Celecoxib Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Celecoxib Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Celecoxib Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Celecoxib Revenue Market Share Forecast by Application (2025-2030)
